19th Aug 2015 12:00
19 August 2015
PureTech Health plc
Notice of Half-Yearly Results
PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a science-driven healthcare company seeking to solve some of the toughest health challenges in disruptive ways, expects to announce its half-yearly results for the six months ended 30 June 2015 at at 7.00am BST on Tuesday 25 August 2015.
Enquiries:
PureTech Daphne Zohar, Chief Executive Officer Stephen Muniz, Executive Vice President, Legal, Finance and Operations Julie DiCarlo, Senior Vice President, Communications and Investor Relations
| +1 617 456 0032 |
FTI Consulting (Communications adviser to PureTech) Ben Atwell Matthew Cole Rob Winder Natalie Garland-Collins | +44 (0) 20 3727 1000 |
About PureTech
PureTech (PureTech Health plc, PRTC.L) is a science-driven healthcare company, seeking to solve some of today's toughest health challenges through disruptive approaches. Based in Boston, Massachusetts, PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concept or peer review in prestigious scientific journals. PureTech is problem-focused and solution-agnostic, looking beyond traditional disciplines and approaching healthcare problems from different perspectives. Focusing on areas of significant unmet medical need, PureTech evaluates more than 650 ideas per year, prioritizing, selecting and testing what it believes to be the most scientifically and commercially promising concepts to advance. PureTech's leading team and board, along with an advisory network of more than 50 experts across multiple disciplines, gives PureTech access to potentially groundbreaking science and technological innovations. For more information, visit www.puretechhealth.com and connect with us on Twitter.
Related Shares:
PureTech